MannKind Corp (MNKD):医療機器:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C7269)
◆英語タイトル:MannKind Corp (MNKD) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7269
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年10月
◆ページ数:47
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
MannKind Corp (MannKind) is a biopharmaceutical company that develops and commercializes inhaled therapeutic products for patients suffering from diabetes and pulmonary arterial hypertension. Its flagship product, Afrezza is a US FDA approved rapid-action inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes. The product consists of a dry powder formulation of human insulin delivered from a small and portable inhaler. The company develops products based on its proprietary Technosphere formulation technology. It has manufacturing facility in Danbury, Connecticut and sells its product through wholesale distributors and specialty pharmacies. MannKind is headquartered in California, the US.

MannKind Corp (MNKD) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
MannKind Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
MannKind Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
MannKind Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
MannKind Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
MannKind Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
MannKind Corp, Medical Equipment, Deal Details 11
Partnerships 11
MannKind and One Drop to Enter into Agreement 11
United Therapeutics to Enter into Licensing Agreement with MannKind 12
Equity Offering 13
MannKind Raises USD28 Million in Private Placement of Shares 13
Mannkind to Raise USD61 Million in Private Placement of Shares 15
MannKind Plans to Raise Funds through Private Placement of Shares upon Exercise of Warrants 17
MannKind Raises USD36.2 Million in Private Placement of Shares 18
Mannkind Raises USD50 Million in Private Placment of Shares 19
MannKind Announces Public Offering Of Common Stock For US$50 Million 21
MannKind Completes Public Offering Of Common Stock And Warrants For US$92 Million 22
MannKind Completes Public Offering Of Units For US$86 Million 23
Debt Offering 25
MannKind Completes First Tranche Of Private Placement Of Notes For US$40 Million 25
MannKind Corp – Key Competitors 27
MannKind Corp – Key Employees 28
MannKind Corp – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Strategy And Business Planning 30
Sep 05, 2017: MannKind Relocates Headquarters to Westlake Village 30
Financial Announcements 31
Aug 02, 2018: MannKind Reports 2018 Second Quarter Financial Results Conference Call to Begin Today at 5:00 PM ET 31
May 09, 2018: MannKind Reports 2018 First Quarter Financial Results 33
Feb 27, 2018: MannKind Reports 2017 Fourth Quarter and Full Year Financial Results 34
Aug 07, 2017: MannKind Reports 2017 Second Quarter Financial Results 36
May 10, 2017: MannKind Reports 2017 First Quarter Financial Results 38
Mar 16, 2017: MannKind Reports 2016 Fourth Quarter and Full Year Financial Results 39
Corporate Communications 40
Feb 06, 2018: MannKind Names David Kendall As Chief Medical Officer 40
Jul 17, 2017: Steven Binder Joins MannKind as Chief Financial Officer 41
Jul 12, 2017: Patrick McCauley Joins MannKind as Chief Commercial Officer 42
Jun 28, 2017: Mannkind draws remaining funds under mann group loan arrangement 43
Jan 04, 2017: MannKind Announces Key Addition to Its Executive Management Ranks 44
Legal and Regulatory 45
Jun 25, 2018: MannKind Set to Join Russell 3000 Index 45
Other Significant Developments 46
Jan 03, 2017: MannKind Receives $1 Million Milestone From RLS 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47

List of Tables
MannKind Corp, Medical Equipment, Key Facts, 2017 2
MannKind Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
MannKind Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
MannKind Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
MannKind Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
MannKind Corp, Deals By Market, 2012 to YTD 2018 9
MannKind Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
MannKind and One Drop to Enter into Agreement 11
United Therapeutics to Enter into Licensing Agreement with MannKind 12
MannKind Raises USD28 Million in Private Placement of Shares 13
Mannkind to Raise USD61 Million in Private Placement of Shares 15
MannKind Plans to Raise Funds through Private Placement of Shares upon Exercise of Warrants 17
MannKind Raises USD36.2 Million in Private Placement of Shares 18
Mannkind Raises USD50 Million in Private Placment of Shares 19
MannKind Announces Public Offering Of Common Stock For US$50 Million 21
MannKind Completes Public Offering Of Common Stock And Warrants For US$92 Million 22
MannKind Completes Public Offering Of Units For US$86 Million 23
MannKind Completes First Tranche Of Private Placement Of Notes For US$40 Million 25
MannKind Corp, Key Competitors 27
MannKind Corp, Key Employees 28
MannKind Corp, Other Locations 29
MannKind Corp, Subsidiaries 29

List of Figures
MannKind Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
MannKind Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
MannKind Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
MannKind Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
MannKind Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
MannKind Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
MannKind Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
MannKind Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ MannKind Corp (MNKD):医療機器:M&Aディール及び事業提携情報(MannKind Corp (MNKD) - Medical Equipment - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆